It turns out, they like us, or so they say. Biomedical researchers should take note that for the second year in a row, U.S. Senate appropriators have declared funding the National Institutes of Health a...
September 7, 2011
Dr. Hannah Kinney of Harvard Medical School presents to the Congressional Biomedical Research Caucus on Sudden Infant Death Syndrome: How Research is Keeping Babies Safe.
Virtually all parents have placed a hand on their sleeping baby at one time or another to see if he or she is still breathing—in fear that the baby may die suddenly and inexplicably during sleep, in fear of what we call sudden infant death syndrome or SIDS. SIDS is the leading cause of postneonatal infant mortality in the United States today. Approximately six SIDS deaths occur each day.
Dr. Kinney is a leading researcher studying the underlining causes of SIDS. Watch as she describes her research. She posits that the idea that SIDS, or a subset of SIDS, is due to a developmental brainstem defect in autonomic and/or respiratory control during sleep. The ultimate goals of the research are to define brainstem abnormalities in living infants and to suggest ways of preventing the abnormalities from leading to sudden infant death.
July 6, 2011
Watch Dr. Joanna Wysocka from Stanford University brief the Congressional Biomedical Research Caucus on Making a Face: The Role of Neural Crest Cells. Dr. Wysocka discusses how recent progress in the burgeoning scientific field of epigenomics allows scientists to annotate, on an unprecedented scale and with high resolution, portions of our genome that are responsible for unique regulation of genes in different cell types of the body. Using examples from her work she will discuss how combining epigenomics with in vitro embryonic stem cell models can reveal information about early events underlying the formation of the human face. Dr. Wysocka’s incredible breakthrough gives hope to the thousands of individuals and families living with—and caring for children diagnosed with—CHARGE Syndrome. CHARGE Syndrome is genetic condition that affects about one in 10,000 children. Dr. Wysocka’s research has earned her several awards, including the 2010 Outstanding Young Investigator Award by the International Society for Stem Cell Research.
June 22, 2011
Dr. Keith Flaherty from Massachusetts General Hospital presents to the Congressional Biomedical Research Caucus on New Therapies for Melanoma. Dr Flaherty discusses cutting edge research for the treatment of advanced melanoma, including immunotherapies, antibodies, and chemotherapeutic combinations. Dr. Flaherty is internationally known for his expertise in clinical and translational research directed on finding molecularly targeted therapies aimed at treating the underlying cause of melanoma.